Partnering opportunities

In-vitro companies looking to collaborate

Business and academia from UK and around the world looking to partner to co-develop in-vitro technology. We can connect you.

We help ambitious, post-start up businesses, to

  • Move into new markets
  • Access funding
  • Use our networks
  • Innovate to grow
  • Find trusted partners
Innovate UK
HM Government
European Commission

Start new search
Refine

52 total opportunities

Filter your results

I’m looking for a partner...
Country of origin

{[{ data.total | number }]} opportunities

52 opportunities

Get updates to this list

The search results below each have a summary which you may find useful in determining if the opportunity is what you’re looking for.

{[{ row.title }]}

{[{ row.summary }]}

Country of origin {[{ row.country }]}

Comprehensive in vitro human immune response testing

A Dutch-British company is specialized in biological and analytical preclinical testing of novel drugs and recently developed a novel in vitro testing... more

Netherlands

In vitro platform for cosmetic ingredients and novel formulations

ingredients in order to generate novel IP protected dermocosmetic products with synergistic activities.The platform is an in vitro multiparametric... more

Spain

In vitro platform for cosmetic ingredients and novel formulations

ingredients in order to generate novel IP protected dermocosmetic products with synergistic activities.The platform is an in vitro multiparametric... more

Spain

Dutch laboratory offers immunology expertise for international collaboration on in vitro diagnostic and vaccine development

The Dutch SME is a young research intensive organization. They are experts on cellular testing with years of experience in the pharmaceutical and diagnostics industry. They work closely with patient organizations... more

Netherlands

Research group offers in-vitro tests for the detection of organotoxicity

from the Northeast of Germany has sucessfully developed in vitro-tests for an early detection of organ failure and assessment of prognosis in critically... more

Germany

A new generation of culture plates for in vitro 2D cell-based assays, that provides a biomechanical physiological micro-environment.

2D in vitro cell culture and cell-based assays are essential tools for both academic and industry-based research for a wide variety of applications, mostly because they are easy to... more

France

Resarch group offers in-vitro tests for the detection of organotoxicity

from the Northeast of Germany has sucessfully developed in vitro-tests for an early detection of organ failure and assessment of prognosis in critically... more

Germany

A new generation of culture plates for in vitro 2D cell-based assays, that provides a biomechanical physiological micro-environment.

2D in vitro cell culture and cell-based assays are essential tools for both academic and industry-based research for a wide variety of applications, mostly because they are easy to... more

France

Highly reliable molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in cancer diagnostics, based on proprietary epigenetic biomarkers

Cervical cancer is the third most common cancer in women world-wide, with approx. 530,000 new cases and 275,000 deaths per year. In contrast to other cancers it mainly affects young... more

Germany

Highly reliable molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in cancer diagnostics, based on proprietary epigenetic biomarkers

Cervical cancer is the third most common cancer in women world-wide, with approx. 530,000 new cases and 275,000 deaths per year. In contrast to other cancers it mainly affects young... more

Germany

Innovative Belgian developer and manufacturer specialized in first-void urine sampling devices for in vitro diagnostics used for detection of infectious diseases, oncology, sports doping control or drug testing is looking for technical cooperation

(urological) cancer detection. Not only the detection and prevention follow-up of urological (bladder or prostate) cancers, but recent literature also showed potential in the detection of other cancers, like lung... more

Belgium

A Scottish (UK) Biomaterials SME seeks European partners for product validation and future collaborations

modified to mimic different tissues and provide a cost effective, animal free 3D matrix to support a range of exciting high growth applications including; • 3D Cell Culture • 3D Bioprinting • Tissue Engineering & Regeneration • In... more

United Kingdom

Small molecules for selective elimination of contaminating pluripotent stem cells from cultures of their differentiated derivatives

cell-derived cardiomyocytes (iPSC-CMs) are contaminating undifferentiated PSCs that remain in the population of differentiated cells which carry the risk of tumour formation. This problem is due to an incomplete... more

Germany

A French Technology Transfer Office offers a novel anti-cancer chemical compound

properties validated in vitro and in vivo. It is a class of chemical agents targeting tubulin polymerization with a high hydrophilic structure and... more

France

Unique Approach for the Study of Immune System Funcionality

Within immune system functionality studies, Enzyme-Linked Immunospot (ELISpot), detects the Effector T cells cytokines secretion with an in vitro system that closely resembles the... more

Italy

An innovative composition for the modulation of the inflammatory processes in joint and infectious diseases, such as arthritis and acne.

can change depending on it. However, the topical administration is preferred as an ointment or cream. Anti-inflammatory properties of active ingredients have been tested through in-vitro... more

Spain

UK-based SME offers novel small molecule for treatment of cancer

Wnt signalling is implicated, such as stonach, liver and pancreatic cancer. Testing on this molecule shows that it displays anti-proliferative activity in pre-clinical in vivo models,... more

United Kingdom

Non-glycosidic analogues of α-GalCer as NKT cell activators

selective modulation of cytokine release. A new family of non-glycosidic analogues of α-GalCer has been developed. These non-glycosidic derivatives have shown a strong activity in vitro... more

Spain

Modified mesenchymal stem cells combined with virus, or virotherapy, for the treatment of cancer with immunotherapies

to the group treated with wild type MSC (not deficient for TLR) and the group without treatment. Moreover, in vitro test shows that the modified cells showed a lower secretion of... more

Spain

Surface modifications and coating technologies for the medical industry.

surface modifications, but also in product development. With years of experience in bringing medical products to market, they can assist in in... more

Netherlands

The right partner not here?

Get in touch and we'll help you post a partnering opportunity

Hash